<DOC>
	<DOCNO>NCT02375750</DOCNO>
	<brief_summary>The primary objective study proof successful use Geistlich Bio-Oss® Geistlich Bio-Gide® ( already register medical device ) bony peri-implant defect due peri-implantitis disease .</brief_summary>
	<brief_title>Treatment Peri-implantitis Lesions Using Biomaterial</brief_title>
	<detailed_description>Patient consider eligible screen visit undergo surgical treatment procedure within 2 week . At day surgery patient randomize 2 treatment group . The subject prescribe postoperative antibiotic ( Azitromax 500 mg day one 250 mg day 2-4 ) . Post-operative pain control Ibuprofen ( 400mg x 3 ) two day subject . Subjects rinse twice daily Chlorhexidine mouth rinse use modify oral hygiene procedure first 5 week heal . Subjects receive professional prophylaxis require . Subjects instructed appropriate oral hygiene throughout study give appropriate oral hygiene instruction . Instructions post-operative care repeat visit . In particular follow point cover first month surgery : Chlorhexidine rinse , avoidance brushing , usage interdental cleaning device , avoidance chew trauma treat area . In addition subject instruct smoke 10 cigarette per day entire study period consume alcohol antibiotic therapy . Sutures remove 14 day . Photos take whole study document heal process . Further follow visit schedule 6 week 3,6,9,12 month post-surgery .</detailed_description>
	<mesh_term>Peri-Implantitis</mesh_term>
	<criteria>age 18 year old Presence periimplantitis A periimplant intraosseous defect least 3 mm defect depth see intraoral radiograph . Clinically probe depth ≥ 5 mm combine bleed and/or pu present site . During surgical exploration intraosseous component least 3 mm deepest point must present . The defect minimum 3 osseous wall ( circumference osseous defect least 270 degree ) . Only 3 4 wall intraosseous defect include . Implants include study must function 12 month . Ability fully understand nature propose surgery ability sign Ethics Committeeapproved inform consent form Subjects diabetes mellitus ( HbA1c &gt; 7.0 ) Subjects take prednisone antiinflammatory prescription drug Subjects take medication know effect gingival growth If patient one defect meeting inclusion criterion , one defect include study General contraindication dental and/or surgical treatment Smokers ( &gt; 10 cigarette per day ) . Pregnant lactate woman Allergy collagen Inability consent participation study and/or accept propose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>